ESB
IONS icon

Essex Savings Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Essex Savings Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,113
Closed -$71K – 394
2019
Q2 		$71K Buy
1,113
+480
+76% +$33.9K 0.03% 395
2019
Q1 		$51K Sell
633
-93
-13% -$6K 0.03% 293
2018
Q4 		$39K Buy
+726
New +$37K 0.02% 317

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Essex Savings Bank's IONS Position: Q3 2019 in Review

Essex Savings Bank sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 1,113 shares — an estimated $71K sold.

Essex Savings Bank first reported a position in IONS in Q4 2018 and held it in 3 quarters. The position peaked at $71K in Q2 2019. 370 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

  • Essex Savings Bank reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Essex Savings Bank sold 1,113 Ionis Pharmaceuticals shares in Q3 2019, an estimated $71K.
  • Essex Savings Bank first reported a position in Ionis Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Essex Savings Bank's Ionis Pharmaceuticals position peaked at $71K in Q2 2019.
  • 370 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on Essex Savings Bank's 13F filing for Q3 2019, filed 30 Oct 2019.